Skip to main content
UXN Co., Ltd. logo

UXN Co., Ltd. — Investor Relations & Filings

Ticker · 337840 ISIN · KR7337840003 KO Manufacturing
Open in API
Filings indexed 212 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country KR South Korea
Listing KO 337840

About UXN Co., Ltd.

https://uxn.co.kr/

UXN Co., Ltd. is a medical device company specializing in the development and production of biosensors for diabetes management. The company manufactures and sells continuous glucose monitoring (CGM) systems and blood glucose sensors, including its flagship product, Gluco-Chaser, designed for individuals with type-I and type-II diabetes. UXN's core technology is an enzyme-free electrochemical platform that utilizes nanoporous platinum sensors. This approach provides enhanced mechanical and chemical stability, aiming to deliver a longer sensor lifespan and more consistent quality compared to traditional enzyme-based sensors.

Recent filings

Filing Released Lang Actions
특허권취득(자율공시) (센서의 정렬이 용이한 트랜스미터를 구비한 연속식 분석물 측정기)
Regulatory Filings
2026-04-30 Korean
특허권취득(자율공시)
Regulatory Filings Classification · 85% confidence The document is a voluntary disclosure in Korean reporting the acquisition of a patent by the company, including details such as patent name, contents, acquisition date, and usage plans. It is not a financial report, earnings release, management change, share transaction, or other specialized category. It is a regulatory announcement of a corporate event and thus falls under the fallback category “Regulatory Filings (RNS).”
2026-04-17 Korean
특허권취득(자율공시)
Regulatory Filings Classification · 75% confidence The document is a short voluntary disclosure (‘자율공시’) announcing the acquisition of a patent by the company, with details of the patent name, contents, owner, and acquisition date. It is not a financial report, management change, dividend notice, or other specialized category, but a regulatory announcement. Therefore, it best fits under Regulatory Filings (RNS).
2026-04-16 Korean
임상시험단계진입ㆍ종료(자율공시)
Regulatory Filings Classification · 50% confidence The document is a voluntary regulatory announcement (자율공시) in Korean by a medical device company entering/exiting a clinical trial phase under the MFDS, detailing trial phase, objectives, approvals, and future plans. It does not present full financial results, dividend notices, management changes, or other specific corporate filings. It is a general regulatory disclosure without fitting into specialized categories (e.g., earnings release, shareholder meeting, capital change). Therefore it best fits the fallback Regulatory Filings category (RNS).
2026-04-03 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is the formal results of the company’s Annual General Meeting held on 2026-03-31, detailing approval of financial statements, dividend resolutions, record date, meeting date, and vote tallies for each agenda item. It clearly constitutes a declaration of voting results from a general meeting. Therefore, it fits the 'Declaration of Voting Results & Voting Rights Announcements' category (Code: DVA).
2026-03-31 Korean
사업보고서 (2025.12)
Annual Report Classification · 100% confidence The document is titled '사업보고서' (Business Report) for the 14th fiscal year (2025), which is the Korean equivalent of an Annual Report (10-K). It contains comprehensive company information, including financial data, management details, shareholding structure, and business operations. It is not an announcement or a summary, but the full report itself, fitting the definition of an Annual Report. FY 2025
2026-03-23 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.